WT Wealth Management Takes $2.44 Million Position in UnitedHealth Group Incorporated $UNH

WT Wealth Management bought a new stake in UnitedHealth Group Incorporated (NYSE:UNH) during the second quarter, HoldingsChannel reports. The fund bought 7,806 shares of the healthcare conglomerate’s stock, valued at approximately $2,435,000.

Several other large investors have also made changes to their positions in UNH. NWF Advisory Services Inc. raised its holdings in shares of UnitedHealth Group by 306.6% during the second quarter. NWF Advisory Services Inc. now owns 2,468 shares of the healthcare conglomerate’s stock worth $770,000 after purchasing an additional 1,861 shares during the last quarter. Alternative Investment Advisors LLC. acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at about $1,260,000. SevenBridge Financial Group LLC grew its holdings in UnitedHealth Group by 19.0% during the second quarter. SevenBridge Financial Group LLC now owns 9,829 shares of the healthcare conglomerate’s stock worth $3,066,000 after acquiring an additional 1,570 shares during the period. Osaic Holdings Inc. lifted its holdings in UnitedHealth Group by 34.7% in the second quarter. Osaic Holdings Inc. now owns 278,252 shares of the healthcare conglomerate’s stock valued at $95,962,000 after acquiring an additional 71,722 shares during the period. Finally, PVG Asset Management Corp acquired a new stake in shares of UnitedHealth Group during the 2nd quarter worth approximately $321,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $341.83 on Monday. The company has a fifty day simple moving average of $339.84 and a 200-day simple moving average of $317.20. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.71. The firm has a market capitalization of $309.65 billion, a price-to-earnings ratio of 17.84, a PEG ratio of 2.23 and a beta of 0.43. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $606.36.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The firm had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. During the same period in the previous year, the business posted $7.15 earnings per share. UnitedHealth Group’s quarterly revenue was up 12.2% on a year-over-year basis. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be paid a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. UnitedHealth Group’s payout ratio is 46.14%.

Wall Street Analyst Weigh In

UNH has been the topic of several recent analyst reports. The Goldman Sachs Group began coverage on shares of UnitedHealth Group in a research note on Tuesday, October 14th. They set a “buy” rating and a $406.00 target price on the stock. Royal Bank Of Canada increased their price target on UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 29th. Leerink Partners set a $410.00 target price on UnitedHealth Group and gave the stock an “outperform” rating in a research note on Wednesday, October 29th. Mizuho boosted their price target on shares of UnitedHealth Group from $300.00 to $430.00 and gave the stock an “outperform” rating in a report on Thursday, October 9th. Finally, Deutsche Bank Aktiengesellschaft lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 target price on the stock. in a research report on Wednesday, October 29th. Seventeen research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat, UnitedHealth Group currently has a consensus rating of “Hold” and a consensus target price of $385.54.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.